섬유근육통 치료 시장 규모는 향후 수년간 안정된 성장이 전망됩니다. 2029년에는 CAGR 4.5%로 성장할 전망이며, 34억 5,000만 달러로 성장이 예측됩니다. 예측 기간의 성장은 노인 인구 증가, 헬스케어 지출 증가, 근골격계 장애 발생률 상승, 보다 나은 치료법을 개발하기 위한 연구 개발 활동의 증가에 기인할 것으로 보입니다. 예측 기간 주요 동향에는 치료 옵션의 진보, 전략적 제휴, 기술 통합 진보, 혁신적 치료 등이 포함됩니다.
섬유근육통 시장은 근골격계 건강에 초점을 맞춘 정부의 활동 및 이니셔티브 증가에 의해 성장할 전망입니다. 이러한 정부의 움직임은 근골격계 질환에 걸린 사람들의 행복을 개선하는 것을 목적으로 한 다양한 정책과 프로그램을 포함하고 있습니다. 예를 들어 2022년 호주를 거점으로 하는 단체인 근골격계 호주는 호주 정부가 'Own Your Health' 이니셔티브를 시작했음을 보고했습니다. 이 4년간의 이니셔티브는 셀프 케어를 촉진하고 근골격계 상태에 대처하는 개인을 지원하는 데 특화된 것입니다. 따라서 정부의 이니셔티브를 통해 근골격계 건강이 중시되게 된 것이 섬유근육통증 시장 확대의 원동력이 되고 있습니다.
섬유근육통 치료 시장의 성장은 고령화 인구의 확대로부터 큰 영향을 받고 있습니다. 이 인구 동태의 변화는 사회나 특정 인구에 있어서의 노인의 비율이 증가하는 것을 특징으로 하고 있습니다. 고령자는 섬유근육통을 개발하기 쉽고, 노화와 관련된 요인으로 증상이 심해지는 경우가 많기 때문에 고령화는 섬유근육통 치료 시장과 특히 관련되어 있습니다. 예를 들어, 유엔 경제사회국은 2022년 7월에 세계 인구의 65세 이상 비율은 2022년 10%에서 2050년에는 16%로 증가할 것으로 예측하고 있다고 보고했습니다. 그 결과 고령화 인구의 증가가 섬유근육통 치료 시장 확대의 중요한 촉진 요인이 되고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장-금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
- 세계의 섬유근육통 치료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
- 최종 이용 산업의 분석
- 세계의 섬유근육통 치료 시장 : 성장률 분석
- 세계의 섬유근육통 치료 시장 실적 : 규모 및 성장(2019-2024년)
- 세계의 섬유근육통 치료 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
- 세계의 섬유근육통 치료 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 섬유근육통 치료 시장 : 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 치료
- 표적 치료
- 세계의 섬유근육통 치료 시장 : 약제 클래스별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 항우울제
- 항 간질 약
- 근육 이완제
- 진통제
- 기타 약물
- 세계의 섬유근육통 치료 시장 : 유통 채널별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 병원 약국
- 소매 약국
- 온라인 약국
- 세계의 섬유근육통 치료 시장 : 치료별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 진통제
- 항우울제
- 항간질약
- 수면 보조제
- 물리치료
- 세계의 섬유근육통 치료 시장 : 표적 치료별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 인지행동요법(CBT)
- 라이프 스타일 변경
- 보완요법
- 특정 증상을 표적으로 한 약
제7장 지역별 및 국가별 분석
- 세계의 섬유근육통 치료 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 섬유근육통 치료 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
- 섬유근육통 치료 시장 : 경쟁 구도
- 섬유근육통 치료 시장 : 기업 프로파일
- Pfizer Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Johnson and Johnson Services Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Roche Holding AG 개요, 제품 및 서비스, 전략 및 재무 분석
- AbbVie Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Novartis AG 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Sanofi SA
- AstraZeneca plc
- Abbott Laboratories
- GlaxoSmithKline plc
- Eli Lilly and Company
- Amgen Inc.
- Viatris Inc.
- Teva Pharmaceutical Industries Ltd.
- Regeneron Pharmaceuticals Inc.
- Mylan NV
- Astellas Pharma Inc.
- Biogen Inc.
- Daiichi Sankyo Co. Ltd.
- Boehringer Ingelheim International GmbH
- Sun Pharmaceutical Industries Ltd.
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
- 섬유근육통 치료 시장 : 새로운 기회를 제공하는 국가(2029년)
- 섬유근육통 치료 시장 : 새로운 기회를 제공하는 부문(2029년)
- 섬유근육통 치료 시장 : 성장 전략(2029년)
제36장 부록
AJY
Fibromyalgia treatment encompasses the use of medications to address fibromyalgia, a multifaceted and persistent medical condition primarily characterized by widespread and often debilitating musculoskeletal pain, coupled with a range of other symptoms. The objective of fibromyalgia treatment is to mitigate the severity of the condition and effectively manage the associated symptoms and complications.
The primary categories of fibromyalgia treatment involve symptomatic treatment and targeted treatment. Symptomatic treatment, also referred to as palliative or supportive care, is geared towards addressing individual symptoms and enhancing the overall quality of life for patients. Various drug classes, including antidepressants, antiepileptics, muscle relaxants, analgesics, and others, are available and distributed through diverse channels such as hospital pharmacies, retail pharmacies, and online pharmacies.
The fibromyalgia treatment market research report is one of a series of new reports from The Business Research Company that provides fibromyalgia treatment market statistics, including fibromyalgia treatment industry global market size, regional shares, competitors with a fibromyalgia treatment market share, detailed fibromyalgia treatment market segments, market trends and opportunities and any further data you may need to thrive in the fibromyalgia treatment industry. This fibromyalgia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The fibromyalgia treatment market size has grown steadily in recent years. It will grow from $2.79 billion in 2024 to $2.9 billion in 2025 at a compound annual growth rate (CAGR) of 3.9%. The growth in the historic period can be attributed to increasing prevalence of fibromyalgia, growing awareness about fibromyalgia, government initiatives, rising disposable incomes.
The fibromyalgia treatment market size is expected to see steady growth in the next few years. It will grow to $3.45 billion in 2029 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to growing geriatric population, rising healthcare expenditure, rising occurrence of musculoskeletal disorders, increasing research and development activities to develop better treatment. Major trends in the forecast period include advancements in treatment options, strategic collaborations, advancements in integration of technology, innovative treatments.
The fibromyalgia market is poised for growth due to increasing government actions and initiatives focused on musculoskeletal health. These government actions encompass a range of policies and programs aimed at improving the well-being of individuals affected by musculoskeletal conditions. For example, in 2022, Musculoskeletal Australia, an organization based in Australia, reported that the Australian government launched the "Own Your Health" initiative. This four-year initiative is dedicated to promoting self-care and supporting individuals dealing with musculoskeletal conditions. Hence, the growing emphasis on musculoskeletal health through government initiatives is a driving force behind the expansion of the fibromyalgia market.
The growth of the fibromyalgia treatment market is significantly influenced by the expanding aging population. This demographic shift is characterized by a rising percentage of elderly individuals within society or a given population. The aging population is particularly relevant to the fibromyalgia treatment market as older individuals are more prone to developing fibromyalgia, and they often face more severe symptoms due to age-related factors. For instance, the United Nations Department of Economic and Social Affairs reported in July 2022 that the global population's proportion aged 65 and older is projected to increase from 10% in 2022 to 16% by 2050. Consequently, the growing aging population is a key driver behind the expansion of the fibromyalgia treatment market.
Prominent companies within the fibromyalgia treatment market are prioritizing the development of cutting-edge solutions, such as microchip technology, to maintain their competitive edge in the industry. Proprietary microchip technology is a specific category that harnesses the potential of microchips to deliver precise and targeted nerve stimulation, thereby alleviating symptoms associated with fibromyalgia. Notably, in November 2022, NeuroMetrix Inc., a US-based medical equipment manufacturer, introduced the Quell Fibromyalgia device as part of its Pathfinder Program, presenting a groundbreaking solution for managing fibromyalgia symptoms. Distinguished as the first and only medical device sanctioned by the U.S. Food and Drug Administration (FDA) for mitigating fibromyalgia symptoms, the Quell Fibromyalgia device employs transcutaneous electrical nerve stimulation (TENS). This device leverages proprietary microchip technology to administer accurate, high-intensity nerve stimulation in a compact, wearable design, optimized through position and motion sensing.
In April 2023, the U.S.-based telemedicine company XRHealth merged with Spain-based VR treatment solutions provider Amelia Virtual Care, operating under the XRHealth brand. This merger marks the unification of XRHealth and Amelia Virtual Care, creating a synergistic entity that allows the two companies to leverage their expertise, technologies, and resources. The collaboration integrates XRHealth's immersive and augmented reality technology with Amelia Virtual Care's extensive virtual reality software designed for mental health professionals.
Major companies operating in the fibromyalgia treatment market are Pfizer Inc., Johnson and Johnson Services Inc., Roche Holding AG, AbbVie Inc., Novartis AG, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Co. Ltd., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Horizon Therapeutics PLC, Endo International PLC, Amneal Pharmaceuticals Inc., Zydus Lifesciences Limited, Lupin Limited.
North America was the largest region in the fibromyalgia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in fibromyalgia treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the fibromyalgia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The fibromyalgia treatment market consists of revenues earned by providing medical diagnosis and evaluation, personalized treatment planning, medication management, pain management clinics and physical therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The fibromyalgia treatment market also includes sales of pain relievers, sleeping aids and anti-anxiety medications. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Fibromyalgia Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on fibromyalgia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for fibromyalgia treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The fibromyalgia treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Symptomatic Treatment; Targeted Treatment
- 2) By Drug Class: Antidepressants; Antiepileptics; Muscle Relaxants; Analgesics; Other Drugs
- 3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
- Subsegments:
- 1) By Symptomatic Treatment: Pain Relievers; Antidepressants; Anti-seizure Medications; Sleep Aids; Physical Therapy
- 2) By Targeted Treatment: Cognitive Behavioral Therapy (CBT); Lifestyle Modifications; Complementary Therapies; Medications Targeting Specific Symptoms
- Companies Mentioned: Pfizer Inc.; Johnson and Johnson Services Inc.; Roche Holding AG; AbbVie Inc.; Novartis AG
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Fibromyalgia Treatment Market Characteristics
3. Fibromyalgia Treatment Market Trends And Strategies
4. Fibromyalgia Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Fibromyalgia Treatment Growth Analysis And Strategic Analysis Framework
- 5.1. Global Fibromyalgia Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Fibromyalgia Treatment Market Growth Rate Analysis
- 5.4. Global Fibromyalgia Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Fibromyalgia Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Fibromyalgia Treatment Total Addressable Market (TAM)
6. Fibromyalgia Treatment Market Segmentation
- 6.1. Global Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Symptomatic Treatment
- Targeted Treatment
- 6.2. Global Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Antidepressants
- Antiepileptics
- Muscle Relaxants
- Analgesics
- Other Drugs
- 6.3. Global Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- 6.4. Global Fibromyalgia Treatment Market, Sub-Segmentation Of Symptomatic Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pain Relievers
- Antidepressants
- Anti-seizure Medications
- Sleep Aids
- Physical Therapy
- 6.5. Global Fibromyalgia Treatment Market, Sub-Segmentation Of Targeted Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cognitive Behavioral Therapy (CBT)
- Lifestyle Modifications
- Complementary Therapies
- Medications Targeting Specific Symptoms
7. Fibromyalgia Treatment Market Regional And Country Analysis
- 7.1. Global Fibromyalgia Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Fibromyalgia Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Fibromyalgia Treatment Market
- 8.1. Asia-Pacific Fibromyalgia Treatment Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Fibromyalgia Treatment Market
- 9.1. China Fibromyalgia Treatment Market Overview
- 9.2. China Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Fibromyalgia Treatment Market
- 10.1. India Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Fibromyalgia Treatment Market
- 11.1. Japan Fibromyalgia Treatment Market Overview
- 11.2. Japan Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Fibromyalgia Treatment Market
- 12.1. Australia Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Fibromyalgia Treatment Market
- 13.1. Indonesia Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Fibromyalgia Treatment Market
- 14.1. South Korea Fibromyalgia Treatment Market Overview
- 14.2. South Korea Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Fibromyalgia Treatment Market
- 15.1. Western Europe Fibromyalgia Treatment Market Overview
- 15.2. Western Europe Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Fibromyalgia Treatment Market
- 16.1. UK Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Fibromyalgia Treatment Market
- 17.1. Germany Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Fibromyalgia Treatment Market
- 18.1. France Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Fibromyalgia Treatment Market
- 19.1. Italy Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Fibromyalgia Treatment Market
- 20.1. Spain Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Fibromyalgia Treatment Market
- 21.1. Eastern Europe Fibromyalgia Treatment Market Overview
- 21.2. Eastern Europe Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Fibromyalgia Treatment Market
- 22.1. Russia Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Fibromyalgia Treatment Market
- 23.1. North America Fibromyalgia Treatment Market Overview
- 23.2. North America Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Fibromyalgia Treatment Market
- 24.1. USA Fibromyalgia Treatment Market Overview
- 24.2. USA Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Fibromyalgia Treatment Market
- 25.1. Canada Fibromyalgia Treatment Market Overview
- 25.2. Canada Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Fibromyalgia Treatment Market
- 26.1. South America Fibromyalgia Treatment Market Overview
- 26.2. South America Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Fibromyalgia Treatment Market
- 27.1. Brazil Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Fibromyalgia Treatment Market
- 28.1. Middle East Fibromyalgia Treatment Market Overview
- 28.2. Middle East Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Fibromyalgia Treatment Market
- 29.1. Africa Fibromyalgia Treatment Market Overview
- 29.2. Africa Fibromyalgia Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Fibromyalgia Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Fibromyalgia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Fibromyalgia Treatment Market Competitive Landscape And Company Profiles
- 30.1. Fibromyalgia Treatment Market Competitive Landscape
- 30.2. Fibromyalgia Treatment Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson and Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
31. Fibromyalgia Treatment Market Other Major And Innovative Companies
- 31.1. Sanofi S.A.
- 31.2. AstraZeneca plc
- 31.3. Abbott Laboratories
- 31.4. GlaxoSmithKline plc
- 31.5. Eli Lilly and Company
- 31.6. Amgen Inc.
- 31.7. Viatris Inc.
- 31.8. Teva Pharmaceutical Industries Ltd.
- 31.9. Regeneron Pharmaceuticals Inc.
- 31.10. Mylan N.V.
- 31.11. Astellas Pharma Inc.
- 31.12. Biogen Inc.
- 31.13. Daiichi Sankyo Co. Ltd.
- 31.14. Boehringer Ingelheim International GmbH
- 31.15. Sun Pharmaceutical Industries Ltd.
32. Global Fibromyalgia Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Fibromyalgia Treatment Market
34. Recent Developments In The Fibromyalgia Treatment Market
35. Fibromyalgia Treatment Market High Potential Countries, Segments and Strategies
- 35.1 Fibromyalgia Treatment Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Fibromyalgia Treatment Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Fibromyalgia Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
